| |
Ramin Shiekhattar, Ph.D.
Professor
Gene Expression and Regulation Program and
Molecular and Cellular Oncogenesis Program
215-898-3896, Office
Introduction
The laboratory of Ramin Shiekhattar, Ph.D., is
interested in the biochemical events that contribute to the development
of cancer. The focus of the laboratory's research is the biochemical
isolation of proteins encoded by genes known to be involved in human
cancer. The Shiekhattar laboratory also studies the role of these
proteins on normal cellular growth and uses cells derived from tumors
to study the function of these genes in cell culture models.
Research Summary
The Shiekhattar laboratory is pursuing research
in two major areas. The first is the molecular mechanism of cancer.
A number of human familial cancer syndromes are caused by the inheritance
of a mutant allele of a tumor suppressor gene. These genes are involved
in regulating cell growth, and they contribute to carcinogenesis
when mutated or lost. Thus, individuals who carry only one functional
copy of a given tumor suppressor gene are predisposed to cancer,
since a second mutation in the same gene will render them lacking
an important negative growth regulator.
The second major research area of the Shiekhattar
laboratory is the epigenetic regulation of gene expression. The
laboratory's goal is to understand the epigenetic regulation of
gene expression in mammalian development and genetic disease. Histone
modifying enzymes are a crucial component of the epigenetic control
of gene activity through the regulation of chromatin state. Shiekhattar's
laboratory has identified a number of factors such as chromatin
remodeling complexes and histone-deacetylases that are involved
in this process.
Recent Scientific Advances
BRCA1/BRCA2-containing
complexes: Over the past several years, the Shiekhattar
laboratory has used biochemical procedures to isolate multiprotein
complexes containing proteins encoded by several tumor suppressor
genes, including BRCA1, BRCA2, Nf1 and Nf2. The laboratory has begun
to decipher the biochemical role of these complexes in regulation
of transcription and DNA repair. Moreover, through mass spectrometric
microsequencing of the constituents of these complexes, Shiekhattar's
laboratory has also identified novel genes whose mutations may contribute
to cancer. The laboratory is analyzing the function of these novel
genes and their pattern of expression in normal as well as malignant
tissues.
Chromatin remodeling:
Recent genetic and biochemical studies have
identified a host of multisubunit complexes that, in an ATP-dependent
manner, are able to alter the structure of the nucleosome. To gain
further insight into the biochemical activity and polypeptide composition
of chromatin remodeling complexes in human cells, the Shiekhattar
laboratory has initiated a systematic analysis of novel chromatin
remodeling activities from human cells. This analysis has revealed
a novel two subunit (135 kDa and 180 kDa) chromatin remodeling complex
displaying a unique mononucleosome DNaseI cleavage pattern. Mass
spectrometric analysis of the two subunits identified the 135 kDa
subunit h. The 180 kDa subunit was identified through the analysis
of expressed sequence tags as a protein closely related to Williams
syndrome transcription factor (WSTF). The gene for WSTF is deleted
in Williams syndrome, a complex developmental disorder marked by
mental retardation, growth defects, cardiovascular disease, dysmorphic
facial features, and a unique cognitive profile. This disorder is
due to a contiguous gene deletion (< 1Mb) at 7q11.23. The Shiekhattar
laboratory has therefore named the chromatin remodeling complex,
WCRF for Williams syndrome transcription factor-related chromatin
remodeling factor. Analysis of the nonredundant GeneBank database
using the BLAST algorithm revealed the presence of another closely
related protein to the WCRF180 subunit, indicating the presence
of a family of WCRF180-related proteins.
Chromatin remodeling
meets chromosome segregation: Nucleosomal
DNA is arranged in a higher-order structure that presents a barrier
to most cellular processes involving protein DNA interactions. The
cellular machinery involved in sister chromatid cohesion, the cohesin
complex, also requires access to the nucleosomal DNA to perform
its function in chromosome segregation. The machineries that provide
this accessibility are termed chromatin remodelling factors. The
Shiekhattar laboratory has isolated a human ISWI (SNF2h)-containing
chromatin remodelling complex that encompasses components of the
cohesin and NuRD complexes. The laboratory has shown that the hRAD21
subunit of the cohesin complex directly interacts with the ATPase
subunit SNF2h. Mapping of hRAD21, SNF2h and Mi2 binding sites by
chromatin immunoprecipitation experiments reveals the specific association
of these three proteins with human DNA elements containing Alu sequences.
The laboratory has found a correlation between modification of histone
tails and association of the SNF2h/cohesin complex with chromatin.
Moreover, the laboratory has shown that the association of the cohesin
complex with chromatin can be regulated by the state of DNA methylation.
Finally, the Shiekhattar laboratory has presented evidence pointing
to a role for the ATPase activity of SNF2h in the loading of hRAD21
on chromatin.
Histone deacetylases:
The Shiekhattar laboratory has identified
a family of histone deacetylase complexes that function through
modifying chromatin structure to keep genes silent. The polypeptide
composition of these complexes has in common a core of two subunits,
HDAC1,2 and BHC110, an FAD-binding protein. The laboratory has isolated
two members of this family, the BHC and XFIM complexes, and shown
that the BHC complex is involved in regulation of neuronal specific
genes. A candidate X-linked mental retardation gene and the transcription
initiation factor II-I (TFII-I) are components of a second member
of this family of complexes. Other subunits of these complexes include
polypeptides associated with cancer causing chromosomal translocations.
These findings not only delineate a novel class of multiprotein
complexes involved in transcriptional repression but also identified
a novel enzyme BHC110 whose activity remains to be determined.
Selected Publications
1. Bochar, D. A., Savard, J., Wang, W., Lafleur,
D. W., Moore, P., Cote, J., and Shiekhattar, R. A novel family of
chromatin remodeling factors related to Williams syndrome transcription
factor. PNAS. USA 97: 1038-1043 (2000).
2. Guenther, Matthew G., Lane, William S., Verdin, Eric, Lazar,
Mitchell A., and Shiekhattar, R. A coreSMRT Corepressor Complex
containing HDAC3 and TBL1, a WD40 Repeat Protein Linked to Deafness.
Genes and Development 14: 1048-1057 (2000).
3. Bochar, D. A., Wang, L., Beniya, H., Kinev, A.., Xue, Y., Lane,
W. S., Wang, W., Kashanchi, F., and Shiekhattar, R. BRCA1 is associated
with a human SWI/SNF-related complex: Linking Chromatin Remodeling
to Breast Cancer. Cell 102: 257-265 (2000).
4. Marmorstein, L., Bochar, Daniel A., Beniya, H., Kinev, A.; Epstein,
J.; Aaronson, Stuart A., and Shiekhattar, R. A human BRCA2 complex
containing a structural DNA binding component influences cell cycle
progression. Cell 104: 247-257 (2001).
5. Lo, W-S, Duggan, L., Tolga Emre, N. C., Belotserkovskya, R.,
Lane, W. S., Shiekhattar, R and Berger, S., L. Snf1-a Histone Kinase
that Works in Concert with Histone Acetyltransferase Gcn5 to Regulate
Transcription. Science 293; 1142-1146 (2001).
6. Hakimi, M-A., Bochar, D.A., Chenoweth, J., Lane, W.S., Mandel,
G., and Shiekhattar, R. A core-BRAF35 complex containing histone
deacetylase mediates repression of neuronal-specific genes. Proc.
Natl. Acad. Sci. USA 99: 7420-7425 (2002).
7. Hakimi M-A, Bochar D. A., Schmiesing J. A. Jr, Dong, Y., Barak,
O. G., Speicher, D. W., Yokomori , K., and Ramin Shiekhattar. A
chromatin remodeling complex that loads cohesin onto human chromosomes.
Nature 418; 994-998 (2002).
8. Hakimi, M-A, Speicher, D.W., and Ramin Shiekhattar. The motor
protein kinesin-1 links neurofibromin and merlin in a common cellular
pathway of neurofibromatosis. J. Biol. Chem 4277; 36909-12 (2002).
|
|